COORDINATED ANTIINFLAMMATORY EFFECTS OF INTERLEUKIN-4 - INTERLEUKIN-4 SUPPRESSES INTERLEUKIN-1 PRODUCTION BUT UP-REGULATES GENE-EXPRESSION AND SYNTHESIS OF INTERLEUKIN-1 RECEPTOR ANTAGONIST

被引:331
作者
VANNIER, E
MILLER, LC
DINARELLO, CA
机构
[1] TUFTS UNIV,SCH MED,DEPT MED,BOSTON,MA 02111
[2] NEW ENGLAND MED CTR HOSP,BOSTON,MA 02111
[3] TUFTS UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02111
关键词
D O I
10.1073/pnas.89.9.4076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Interleukin 1 receptor antagonist (IL-1ra), a naturally occurring polypeptide with amino acid sequence homology to interleukin 1-alpha (IL-1-alpha) and interleukin 1-beta (IL-1-beta), prevents Escherichia coli-induced shock and death. Both IL-1 and IL-1ra are produced by monocytes stimulated with lipopolysaccharide (LPS). Because interleukin 4 (IL-4) suppresses IL-1 production, we investigated whether IL-4 modulated IL-1ra synthesis in LPS-stimulated human peripheral blood mononuclear cells. IL-1-beta and IL-1ra were measured by specific RIAs. IL-4 alone (0.01-100 ng/ml) did not stimulate IL-1-beta-synthesis but rather induced IL-1ra (4.82 +/- 0.94 ng/ml). LPS induced synthesis of both IL-1-beta (6.67 +/- 1.06 ng/ml) and IL-1ra (10.77 t 2.79 ng/ml). IL-4 suppressed LPS-induced IL-1-beta-mRNA accumulation and synthesis. However, IL-4 acted synergistically with LPS in inducing IL-1ra. IL-4 enhanced LPS-induced IL-1ra mRNA accumulation 4-fold and IL-1ra protein synthesis nearly 2-fold. Moreover, IL-1ra mRNA levels were maximal after 6 hr of exposure to LPS but peaked within the first 3 hr in the presence of IL-4. IL-4 added as late as 12 hr after LPS stimulation still enhanced IL-1ra synthesis. In human peripheral blood mononuclear cells stimulated with IL-1-alpha, IL-4 markedly suppressed IL-1-beta-production but enhanced IL-Ira synthesis > 2-fold. Because IL-4 favors synthesis of the natural antagonist IL-1ra over synthesis of the agonist IL-1, IL-4 may exert potent antiinflammatory effects on host responses to Gram-negative infections.
引用
收藏
页码:4076 / 4080
页数:5
相关论文
共 43 条
  • [1] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1694 - 1697
  • [2] AREND WP, 1985, J IMMUNOL, V134, P3868
  • [3] ATKINS MB, 1992, IN PRESS J CLIN ONCO
  • [4] PURIFICATION, CLONING, EXPRESSION AND BIOLOGICAL CHARACTERIZATION OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN
    CARTER, DB
    DEIBEL, MR
    DUNN, CJ
    TOMICH, CSC
    LABORDE, AL
    SLIGHTOM, JL
    BERGER, AE
    BIENKOWSKI, MJ
    SUN, FF
    MCEWAN, RN
    HARRIS, PKW
    YEM, AW
    WASZAK, GA
    CHOSAY, JG
    SIEU, LC
    HARDEE, MM
    ZURCHERNEELY, HA
    REARDON, IM
    HEINRIKSON, RL
    TRUESDELL, SE
    SHELLY, JA
    EESSALU, TE
    TAYLOR, BM
    TRACEY, DE
    [J]. NATURE, 1990, 344 (6267) : 633 - 638
  • [5] INTERLEUKIN-1 (IL-1) GENE-EXPRESSION, SYNTHESIS, AND EFFECT OF SPECIFIC IL-1 RECEPTOR BLOCKADE IN RABBIT IMMUNE-COMPLEX COLITIS
    COMINELLI, F
    NAST, CC
    CLARK, BD
    SCHINDLER, R
    LLERENA, R
    EYSSELEIN, VE
    THOMPSON, RC
    DINARELLO, CA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) : 972 - 980
  • [6] HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B
    DEFRANCE, T
    AUBRY, JP
    ROUSSET, F
    VANBERVLIET, B
    BONNEFOY, JY
    ARAI, N
    TAKEBE, Y
    YOKOTA, T
    LEE, F
    ARAI, K
    DEVRIES, J
    BANCHEREAU, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) : 1459 - 1467
  • [7] DEFRANCE T, 1987, J IMMUNOL, V139, P1135
  • [8] DINARELLO CA, 1991, BLOOD, V77, P1627
  • [9] BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO
    DINARELLO, CA
    THOMPSON, RC
    [J]. IMMUNOLOGY TODAY, 1991, 12 (11): : 404 - 410
  • [10] DONNELLY RP, 1991, J IMMUNOL, V146, P3431